BriaCell Therapeutics Corp (BCTXW) — Strategic Asset Allocation Index
BriaCell Therapeutics Corp (BCTXW) has a Strategic Asset Allocation Index of 1.9% as of January 2026. Strategic assets (PP&E of $- plus long-term investments of $582.46K) total $582.46K, measured against net assets of $29.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see BriaCell Therapeutics Corp stock valuation.
SAAI
Strategic Assets
PP&E
Net Assets
BriaCell Therapeutics Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how BriaCell Therapeutics Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2022. As of January 2026, the index stands at 1.9%, representing strategic assets of $582.46K against net assets of $29.96 Million USD. See net asset quality index of BriaCell Therapeutics Corp to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for BriaCell Therapeutics Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for BriaCell Therapeutics Corp from 2017 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore net asset growth rate of BriaCell Therapeutics Corp to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.00 | $- | $2.00 | $10.33 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $- | $2.00 | $57.26 Million | ▼ 0.0 pp |
| 2018 | 0.0% | $2.00 | $- | $2.00 | $945.02K | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $- | $2.00 | $750.23K | — |